You just read:

Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65

News provided by

Janssen Research & Development, LLC

Dec 09, 2013, 07:01 ET